RxDoctor Payments Data

Monica Blair

Family · Franklin, KYNPI 1962938910

Payments from drug & device makers

$2,170in general payments, 2019–2025

Across 119 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$603
  • Novo Nordisk$277
  • Pfizer$181
  • GSK$180
  • Lilly USA, LLC$172
  • Dexcom, Inc.$142
  • plus $614 from 14 others

What the payments were for

  • Food & beverage$2,10497%
  • Education$663%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,170 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide136$145,548
TrulicityDulaglutide56$57,355
OzempicSemaglutide33$45,101
FarxigaDapagliflozin Propanediol50$41,919
JardianceEmpagliflozin35$35,214
VraylarCariprazine Hcl30$33,117
EliquisApixaban23$29,830
LinzessLinaclotide28$24,996
Tresiba Flextouch U-100Insulin Degludec25$24,124
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$23,987
Repatha SureclickEvolocumab30$20,010
XareltoRivaroxaban16$17,661
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$9,612
Breo ElliptaFluticasone/Vilanterol11$5,531
SymbicortBudesonide/Formoterol Fumarate11$4,975

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$172$202,903192 claims
AbbVieVraylar, Linzess, Synthroid$603$58,80169 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$129$56,50578 claims
Novo NordiskOzempic$277$45,10133 claims
PfizerEliquis$181$29,83023 claims
GSKTrelegy Ellipta, Breo Ellipta$180$29,51848 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Franklin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →